๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Herpes Zoster
Clinical trial register · China

Herpes Zoster Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 11 Zhengzhou 3 Wuhan 3 Xinxiang 2 Shijiazhuang 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing11 Zhengzhou3 Wuhan3 Xinxiang2 Shijiazhuang2
All 12 locations
Target enrolment
to

Herpes Zoster trials in China

23 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
NCT07585370Herpes Zoster
Jiangsu Province Centers for Disease Control and Prevention
Observational
24,740
Nanjing
2026-03-06
Recruiting
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
NCT07400003Herpes Zoster, mRNA Vaccine
Sinovac Biotech Co., Ltd
Phase 1/2
519
Xinjiang
2026-01-06
Recruiting
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
NCT07307170Herpes Zoster, Mirogabalin, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-12-15
Recruiting
The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster
NCT07378046Herpes Zoster, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-12-15
Active, closed
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
NCT07293065Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 3
12,000
Shijiazhuang, Zhengzhou, Wuhan, Kunming
2025-12-15
Recruiting
The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster
NCT07307976Herpes Zoster, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-12-15
Recruiting
The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster
NCT07361796Herpes Zoster, Pain, Postherpetic Neuralgia
Beijing Tiantan Hospital
Not applicable
832
Beijing
2025-12-15
Recruiting
The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes Zoster
NCT07378059Herpes Zoster, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-12-15
Recruiting
The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster
NCT07361809Herpes Zoster, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-12-15
Recruiting
The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster
NCT07370389Herpes Zoster, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-12-15
Recruiting
The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster
NCT07370402Herpes Zoster, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-12-15
Recruiting
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
NCT07099157Herpes Zoster
Peking University Third Hospital
Phase 4
140
Beijing
2025-08-25
Active, closed
Clinical Efficacy and Safety of Tender Point Infiltration (TPI) for Acute and Subacute Zoster Associated Pain
NCT06344403Herpes Zoster, Local Infiltration, Acute Pain
Beijing Tiantan Hospital
Not applicable
136
Beijing
2025-06-01
Not yet open
Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain
NCT06914206Herpes Zoster
Beijing Tiantan Hospital
Not applicable
184
Beijing
2025-04-01
Active, closed
Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older
NCT06851832Herpes Zoster, Herpes Zoster Vaccine
Ab&B Bio-tech Co., Ltd.JS
Phase 1/2
960
Xuchang
2025-02-16
Not yet open
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine
NCT06801509Herpes Zoster
Sinocelltech Ltd.
Phase 1/2
540
Dazhou
2025-02-15
Not yet open
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
NCT06654700Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 3
1,200
Zhengzhou
2024-12-09
Recruiting
Electroacupuncture Regulation of Immune Cells in Herpes Zoster
NCT06643247Herpes Zoster, Electroacupuncture, Immune
First People's Hospital of Hangzhou
Not applicable
8
Hangzhou
2024-11-11
Active, closed
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
NCT06447779Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 3
25,000
Shijiazhuang, Zhengzhou, Wuhan, Kunming
2024-07-13
Recruiting
Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia
NCT06449547Herpes Zoster
Huazhong University of Science and Technology
Observational
600
Wuhan
2024-06-21
Recruiting
A Phase โ…ข Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
NCT06088745Vaccine-Preventable Diseases, Herpes Zoster
Beijing Luzhu Biotechnology Co., Ltd.
Phase 3
4
Zhenjiang
2023-09-28
Active, closed
Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above
NCT05856084Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 2
924
Xinxiang
2023-05-07
Active, closed
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above
NCT05636436Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 1
132
Xinxiang
2022-12-07
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/herpes-zoster

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies listing the condition Herpes Zoster.

How many Herpes Zoster trials are recruiting in China?

14 of the 23 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Herpes Zoster), 23 studies
PhaseStudiesRecruitingShare
Not applicable11947.8%
Phase 34117.4%
Phase 1/23113%
Observational228.7%
Phase 1104.3%
Phase 2104.3%
Phase 4114.3%

Most active sponsors

Lead sponsors with the most studies (Herpes Zoster)
Lead sponsorStudiesRecruiting
Beijing Tiantan Hospital108
MAXVAX Biotechnology Limited Liability Company50
Ab&B Bio-tech Co., Ltd.JS10
Beijing Luzhu Biotechnology Co., Ltd.11
First People's Hospital of Hangzhou11
Huazhong University of Science and Technology11
Jiangsu Province Centers for Disease Control and Prevention11
Peking University Third Hospital11
Sinocelltech Ltd.10
Sinovac Biotech Co., Ltd11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.